Vitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon

Evaluation of the correlation between vitamin D receptor polymorphism and the response to treatment in chronic hepatitis C patients

Relation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

Evaluation of vitamin D receptor gene polymorphism and serum 25-hydroxy vitamin d level in patients with hepatocellular carcinoma

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy